Literature DB >> 26486291

ANALYSIS OF POLYMORPHISMS IN THE INTERLEUKIN 18 GENE PROMOTOR (-137 G/C AND -607 C/A) IN PATIENTS INFECTED WITH HEPATITIS C VIRUS FROM THE BRAZILIAN AMAZON.

Kemper Nunes dos Santos1, Marcella Kelly Costa de Almeida1, Amanda Alves Fecury1, Carlos Araújo da Costa1, Luísa Caricio Martins1.   

Abstract

BACKGROUND: The hepatitis C virus has been recognized as the leading cause of chronic liver disease in the world. Host genetic factors have been implicated in the persistence of hepatitis C virus infection. Single nucleotide polymorphisms at positions -607 C/A (rs1946518) and -137 G/C (rs187238) in the IL-18 gene promoter have been suggested to be associated with delayed hepatitis C virus clearance and persistence of the disease.
OBJECTIVE: Identify these polymorphisms in a population infected with hepatitis C virus from the Brazilian Amazon region.
METHODS: In a cross-sectional analytical study conducted in Belém, Pará, Brazil, 304 patients infected with hepatitis C virus were divided into two groups: group A, patients with persistent infection; group B, patients with spontaneous clearance. The control group consisted of 376 volunteers not infected with hepatitis C virus. Samples were analyzed by RT-PCR for the detection of viral RNA and by RFLP-PCR to evaluate the presence of the -137 G/C and -607 C/A IL-18 gene promoter polymorphisms.
RESULTS: Comparison of polymorphism allele frequencies between the patient and control groups showed a higher frequency of allele C at position -607 among patients (P=0.02). When the association between the polymorphisms and viral infection was analyzed, patients carrying genotype C/A at position -607 were found to be at higher risk of persistent hepatitis C virus infection (P=0.03).
CONCLUSION: The present results suggest a possible role of the -607 IL-18 gene promoter polymorphism in the pathogenesis of hepatitis C virus infection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26486291     DOI: 10.1590/S0004-28032015000300013

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  4 in total

1.  Direct-Acting Antiviral Agents for HCV Infection.

Authors:  Madhumita Premkumar; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2018-03-26

2.  IL18 Polymorphism and Periodontitis Susceptibility, Regardless of IL12B, MMP9, and Smoking Habits.

Authors:  Patrícia Yumeko Tsuneto; Victor Hugo de Souza; Josiane Bazzo de Alencar; Joana Maira Valentini Zacarias; Cléverson O Silva; Jeane Eliete Laguila Visentainer; Ana Maria Sell
Journal:  Mediators Inflamm       Date:  2019-04-01       Impact factor: 4.711

3.  Inflammasomes and their roles in the pathogenesis of viral hepatitis and their related complications: An updated systematic review.

Authors:  Maryam Dadmanesh; Mohammad Mehdi Ranjbar; Khodayar Ghorban
Journal:  Immunol Lett       Date:  2019-03-01       Impact factor: 3.685

4.  Effect of Sofosbuvir Plus Daclatasvir in Hepatitis C Virus Genotype-4 Patients: Promising Effect on Liver Fibrosis.

Authors:  Asmaa M Abdel-Aziz; Mohamed A Ibrahim; Azza A El-Sheikh; Maha Y Kamel; Nagwa M Zenhom; Salam Abdel-Raheim; Hisham Abdelhaleem
Journal:  J Clin Exp Hepatol       Date:  2017-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.